Skip to main content

Published locations for Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events

User login

  • Reset your password
  • /content/tocilizumab-looks-promising-corticosteroid-refractory-anti-pd-1-related-adverse-events
  • /hematologynews/article/147537/immuno-oncology/tocilizumab-looks-promising-corticosteroid-refractory
  • /rheumatologynews/article/147537/immuno-oncology/tocilizumab-looks-promising-corticosteroid
  • /oncologypractice/article/147537/immuno-oncology/tocilizumab-looks-promising-corticosteroid
  • /hematology-oncology/article/147537/immuno-oncology/tocilizumab-looks-promising-corticosteroid
  • /rheumatology/article/147537/immuno-oncology/tocilizumab-looks-promising-corticosteroid-refractory